# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Falcon Scott (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX002-SYN
- Date: 2026-04-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ottilie Harrow-Mbeki, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Three-month review of blood pressure on lifestyle measures; first aid and cold-injury training. **S**

## History of present illness

Mr. Scott returns three months after his blood pressure was first found to be raised and about eight weeks before he leaves. His home readings over the last week average 134/85 mmHg, despite less salt, regular training and keeping alcohol within limits. He has finished a four-day wilderness first aid course, including frostbite, hypothermia, rewarming, splinting, and packaging a casualty in a sledge. He has not smoked for thirteen weeks and wants to keep taking varenicline through the voyage, when he fears the craving will return. He feels well and is sleeping well. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Seven-day average 134/85 mmHg after three months of lifestyle measures |
| Training | Wilderness first aid course with cold-injury modules completed |
| Tobacco | No pipe for thirteen weeks |
| Departure | In about eight weeks |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or swelling |
| Neurological | Negative | No headache |
| Psychiatric | Negative | Mood good; sleeping six to seven hours |

3 systems reviewed. **S**

## Current medications

- Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration (0.5 mg once daily for 3 days, then twice daily for 4 days) **S**
- Losartan 50 mg tablet, one tablet by mouth daily; stop during vomiting, diarrhea or dehydration and restart when eating and drinking normally **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/86 mmHg; pulse 62 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 71 kg; BMI 23.7 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 136/86, pulse 62, weight 71.0 kg |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear to auscultation bilaterally |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential hypertension, stage 1, above target after three months of lifestyle measures** (I10). Home average 134/85 mmHg after three months, still above the target below 130/80, so medicine is now advised, as planned at the consultation. Losartan, an angiotensin receptor blocker, is chosen: thiazide diuretics add to fluid and salt loss in the cold and on long marches, and beta-blockers can worsen cold hands and feet and blunt the response to exercise. Starting now leaves about eight weeks to check kidney function and tolerance before departure. **S**
   - Start losartan 50 mg daily.
   - Sick-day rule, in writing: stop losartan during vomiting, diarrhea, or dehydration, and restart when eating and drinking normally for 24 hours.
   - Electrolytes and creatinine in two to four weeks, and before departure.
   - Report lightheadedness on standing.
2. **Nicotine dependence, pipe tobacco, in early remission** (F17.290). Abstinent for thirteen weeks; the first twelve-week course of varenicline is complete. **S**
   - Continue varenicline for a second twelve-week course through the voyage, for relapse prevention.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, validated technique, average of two readings (target below 130/80 mmHg) | Every visit | Completed today | 136/86 mmHg |
| Self-management | Home blood pressure monitoring to confirm the diagnosis and guide treatment | At diagnosis and when treatment changes | Completed today | Seven-day average 134/85 mmHg; above target; losartan started |
| Examination | Weight, BMI, and cardiac auscultation | Every visit | Completed today | 71.0 kg, BMI 23.7; no murmur |
| Medication safety | Medication adherence, side effects, and sick-day rules | When starting a medicine, then every visit | Completed today | Losartan started; sick-day rule given in writing |
| Laboratory | Basic metabolic panel: sodium, potassium, creatinine, eGFR | Baseline; 2 to 4 weeks after starting an ARB; then every 6 months on an ARB | Ordered | Due two to four weeks after starting losartan |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Up to date | 8 mg/g at the six-week visit |
| Examination | Fundoscopic examination | Yearly | Up to date | No hypertensive changes at the preventive visit |
| Imaging | Echocardiogram | Only for stage 2 hypertension, suspected left ventricular hypertrophy, or clinical change | Not indicated | Stage 1; no left ventricular hypertrophy |
| Self-management | Tobacco use and cessation support (varenicline with counseling) | Every visit | Completed today | Abstinent for thirteen weeks; second course of varenicline |
| Self-management | Frostbite and hypothermia prevention and field treatment training | Before departure | Completed today | Wilderness first aid course completed, with frostbite, hypothermia and rewarming practice |
| Self-management | Expedition nutrition plan: energy, weight, and vitamin C | Planned before departure, then weekly in the field | Ordered | Rations and vitamin C supply being packed; to be confirmed at the pre-departure visit |

## Goal progress

- Home blood pressure average below 130/80 mmHg before departure. In progress; target 2026-05-26. **S**
- No tobacco from the quit date, confirmed at each visit. In progress; target 2026-05-26. **S**
- Complete a wilderness first aid course with frostbite, hypothermia and evacuation practice before departure. Outcome by 2026-04-21: Course completed, with rewarming and casualty-packaging practice. **S**
- A written expedition medical plan covering nutrition and vitamin C, cold injury, altitude, mental health support, medicines and evacuation, agreed before departure. In progress; target 2026-05-26. **S**

## Medication changes

- Started: Losartan 50 mg tablet, one tablet by mouth daily; stop during vomiting, diarrhea or dehydration and restart when eating and drinking normally **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Circulation 2025;152(11):e114-e218) (2025), American Heart Association and American College of Cardiology
- CMID: Clinical Monitoring Intelligence Database, hypertension monograph (2026), Aether Forge
- Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024), Wilderness Medical Society
- Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (Dow J, et al. Wilderness Environ Med 2019;30(4S):S47-S69) (2019), Wilderness Medical Society
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force

## Follow-up

- Pre-departure review in five weeks with electrolytes and creatinine; telephone the clinic for lightheadedness. **S**
- Next scheduled visit 2026-05-26: pre-departure review: electrolytes on losartan, blood pressure, mental health, and the expedition medical plan. **S**
